New Analyst Forecast: $LIN Given $504.0 Price Target

We just received data on a new analyst forecast for $LIN. Geoff Haire from UBS set a price target of 504.0 for LIN.

To track analyst ratings and price targets for $LIN, check out Quiver Quantitative's $LIN forecast page.

$LIN Price Targets

Multiple analysts have issued price targets for $LIN recently. We have seen 7 analysts offer price targets for $LIN in the last 6 months, with a median target of $510.0.

Here are some recent targets:

• Geoff Haire from UBS set a target price of $504.0 on 07/09/2025
• Patrick Cunningham from Citigroup set a target price of $535.0 on 06/30/2025
• Arun Viswanathan from RBC Capital set a target price of $576.0 on 06/13/2025
• Jeffrey Zekauskas from JP Morgan set a target price of $470.0 on 05/02/2025
• John Roberts from Mizuho set a target price of $510.0 on 02/07/2025
• John McNulty from BMO Capital set a target price of $510.0 on 02/07/2025
• Marc Bianchi from TD Cowen set a target price of $515.0 on 01/13/2025

$LIN Congressional Stock Trading

Members of Congress have traded $LIN stock 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $LIN stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $100,000 on 04/07 and 2 sales worth up to $150,000 on 05/12, 02/24.
• REPRESENTATIVE JONATHAN L. JACKSON sold up to $100,000 on 05/07.
• REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 04/08, 02/25, 01/13.
• REPRESENTATIVE GEORGE WHITESIDES sold up to $250,000 on 03/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$LIN Insider Trading Activity

$LIN insiders have traded $LIN stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $LIN stock by insiders over the last 6 months:

• SEAN DURBIN (Executive VP, North America) has made 0 purchases and 2 sales selling 7,261 shares for an estimated $3,314,272.
• JUERGEN NOWICKI (Executive VP, Engineering) has made 0 purchases and 3 sales selling 6,782 shares for an estimated $3,117,142.
• GUILLERMO BICHARA (Exec VP & Chief Legal Officer) sold 4,833 shares for an estimated $2,231,154
• DAVID P STRAUSS (Executive VP, Chief HR Officer) has made 0 purchases and 2 sales selling 4,464 shares for an estimated $2,071,757.
• ROBERT L WOOD sold 2,900 shares for an estimated $1,323,154
• BINOD PATWARI (Senior Vice President - APAC) sold 1,400 shares for an estimated $640,570

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LIN Hedge Fund Activity

We have seen 973 institutional investors add shares of $LIN stock to their portfolio, and 807 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 3,645,212 shares (+38.0%) to their portfolio in Q1 2025, for an estimated $1,697,356,515
• CAPITAL INTERNATIONAL INVESTORS removed 2,694,019 shares (-28.6%) from their portfolio in Q1 2025, for an estimated $1,254,443,007
• JANUS HENDERSON GROUP PLC removed 1,251,705 shares (-83.5%) from their portfolio in Q1 2025, for an estimated $582,843,916
• WELLINGTON MANAGEMENT GROUP LLP added 1,182,157 shares (+18.6%) to their portfolio in Q1 2025, for an estimated $550,459,585
• PROFICIO CAPITAL PARTNERS LLC removed 1,095,378 shares (-99.8%) from their portfolio in Q1 2025, for an estimated $510,051,811
• CAPITAL WORLD INVESTORS removed 753,810 shares (-6.5%) from their portfolio in Q1 2025, for an estimated $351,004,088
• MORGAN STANLEY removed 699,965 shares (-8.9%) from their portfolio in Q1 2025, for an estimated $325,931,702

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.